MODIFICATION
B -- Centralized Chemopreventive Agent Repository and Chemistry Support
- Notice Date
- 8/28/2009
- Notice Type
- Modification/Amendment
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- SSPCPSB9500347
- Archive Date
- 9/26/2009
- Point of Contact
- Dianne Gray, Phone: 301-496-6987, Virginia A DeSeau, Phone: 301-435-3798
- E-Mail Address
-
graydi@mail.nih.gov, vd9t@nih.gov
(graydi@mail.nih.gov, vd9t@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This Notice is a revision of the Sources Sought Notice previously posted on January 5, 2009 and is intended to provide updated information regarding the requirement. Please be advised that the notice dated 1/5/2009 with a response date of 1/21/2009 is the OLD NOTICE and is no longer revelant. Sources Sought Notice No: SS-PCPSB-5003-47 Amendment Number One Title: "Centralized Chemopreventive Agent Repository and Chemistry Support" The Division of Cancer Prevention (DCP) of the National Cancer Institute (NCI) is planning to award a contract for a centralized chemopreventive agent repository with multiple functions and duties. This Sources Sought notice (SS) is for informational and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the National Cancer Institute (NCI). The purpose of this SS is to locate QUALIFIED SMALL BUSINESS CONCERNS with the ability to perform the requirements of the program. Small Business Concerns include: Small Disadvantaged Businesses (SDB), Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZONE) Small Businesses, Veteran-Owned Small Business (VOSB), Service-Disabled Veteran-Owned Small Businesses, and 8(a) Small Business. ONLY SMALL BUSINESSES SHOULD RESPOND TO THIS NOTICE. The NCI does not intend to award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted in response to this notice. As a result of this Sources Sought notice, the NCI may issue a Request for Proposal (RFP). THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. The DCP is seeking capability statements from all eligible Small Businesses as stated above, under NAICS Code: 541690 with a size standard of $7 million dollars. The purpose of the acquisition is to provide services to support many different agent development functions critical to chemoprevention research. These functions are generally described as sourcing, acquiring, documenting, storing, quality testing, custom manufacturing, packaging and labeling, distributing and tracking both pre-clinical investigational agents for basic research and clinical supplies for human clinical trials. 1) The Core Competencies required include cost estimation, agent receiving, specification setting, analytical testing, material acceptance and release, packaging and labeling, stability testing, proper environmental storage, shipping domestically and abroad, inventory tracking of clinical trial materials, agent returns and destruction or disposal of investigational agents and clinical study supplies. All information to support regulatory filings to health authorities, scientific reports for research documentation and manuscript publication will be maintained by the contractor and provided to DCP, when requested. If the contract requires specialty [subcontracted] services for the timely development of agents identified through DCP programs (e.g., the DCP RAPID program), A well-organized and effective subcontracting administrative unit will be needed. 2) An offeror's facility must have sufficient space for: storage of pre-clinical agents (estimated at 5,000 sq. ft. of useable space); storage of clinical study supplies (estimated at 5,000 sq. ft.of useable space); a staging/quarantine area; separate shipping and receiving rooms; and, space devoted to an analytical chemistry unit (estimated at 5,000 sq. ft.) with a detached weighing area. The space must include areas for refrigerated and other environmentally-controlled storage conditions (e.g., light protection, humidity controlled cabinets - approximately 500 sq. ft.). 3) A comprehensive and continuously updated computerized logistics management system containing inventory movements, quantities on hand, expiration or re-test information, Certificates of Analysis and analytical testing results, on all materials, must be made available electronically to the Project Officer/Contracting Officer's Technical Representative on demand through a secure, password-protected, DCP-dedicated server. 4) The Contractor will be required to demonstrate experience and competency in domestic and international shipping of pharmaceuticals, especially through U.S. and foreign Customs, the FDA, and other Health Authorities in accordance with applicable regulations. The Contractor must have experience in obtaining a Quality Persons Determination for agents shipped into the European Union. CAPABILITY CRITERIA - Capabilities will be judged based on the following criteria: 1. History of key personnel having prior experience as a team in core competencies including providing supplies for clinical trials. 2. Proof of adequate facility space 3. Demonstration of a working computerized logistics management system 4. Demonstrated experience with international shipping of pharmaceuticals AT THIS TIME, ONLY CAPABILITY STATEMENTS FROM INTERESTED, QUALIFIED SMALL BUSINESSES ARE BEING REQUESTED. THIS NOTICE IS NOT A REQUEST FOR PROPOSALS. Capability statements must specify the offeror's business size and type, and demonstrate similar work that has been performed in the past five years and the dollar value of that work. The required service is defined as NAICS code previously stated. Small businesses that believe that they have the ability to satisfy all of the above stated competencies, and who meet the stated size standards, are encouraged to submit a capability statement. The capability statement should be limited to no more than fifteen (15) pages (including all attachments, charts, etc.) using a 12 point font size at a minimum. All proprietary information should be marked as such. The capability statement should include an indication of current certified small business status; this indication should be clearly marked on the first page of the statement (preferably placed under the eligible small business concern's name and address). Responses will be reviewed only by NIH personnel and will be held in a confidential manner. If responses indicate the likelihood of satisfactory competition among qualified businesses, the anticipated solicitation will be restricted to small businesses only. All capability statements sent in response to this SOURCES SOUGHT notice must be submitted electronically (via email) to Dianne M. Gray, Contracting Officer Representative, at graydi@mail.nih.gov in either MS Word or WordPerfect, or ADOBE Document Format (PDF), by September 11, 2009, 3:30PM Eastern Time. Questions regarding this requirement must be submitted in writing and directed to Dianne M. Gray at the above email address before the closing date of this notice. All responses must be received by the specified due date and time in order to be considered. Old Notice (listed below is irrevelant, please disregard the below information) Title: “Centralized Chemopreventive Agent Repository and Chemistry Support” The Division of Cancer Prevention (DCP) of the National Cancer Institute (NCI) is planning to award, through full and open competition, a contract for a centralized chemopreventive agent repository with multiple functions and duties. This Sources Sought Notice (SS) is for informational and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the National Cancer Institute (NCI). The purpose of the SS is to locate potential SMALL BUSINESS CONCERNS with the ability to perform the requirements of the program. Small Business Concerns include: Small Disadvantaged Businesses (SDB), Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZONE) Small Businesses, Veteran-Owned Small Business (VOSB) and Service-Disabled Veteran-Owned Small Businesses. ONLY SMALL BUSINESSES SHOULD RESPOND TO THIS NOTICE. The NCI does not intend to award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted in response to this notice. As a result of this Sources Sought Notice, the NCI may issue a Request for Proposal (RFP). THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. The purpose of the acquisition is to provide services supporting many different agent development functions critical to chemoprevention research. These functions are generally described as obtaining, documenting, storing, maintaining, testing, manufacturing and distributing both pre-clinical investigational agents and clinical trial materials. This may include sourcing, sub-contracting, procuring, receiving, analytical testing, packaging and labeling, stability testing, proper storage, shipping, tracking and destruction of chemopreventive study materials. All documentation to support regulatory and scientific requirements will be maintained by the contractor and provided to DCP as needed. The contract will also require specialty services, as needed, for the timely development of agents identified through DCP programs (e.g. the DCP RAPID program). A comprehensive and continuously updated electronic inventory tracking system and real-time laboratory reporting system with integrated tracking capabilities giving current information must be available to the project officer through a secure, password-protected dedicated server. A contractor will be required to demonstrate experience and competency in domestic and international shipping of pharmaceuticals through Customs and in accordance with FDA regulations. A contractor’s facility must have sufficient space for: storage of pre-clinical agents (estimated at 5,000 sq. feet of useable space); storage of clinical study agents (estimated at 5,000 sq feet of useable space), a staging/quarantine area, shipping and receiving rooms, space devoted to an analytical chemistry unit (estimated at 5,000 sq. ft) with a separated weighing area. The space must include area for refrigerated and other environmentally-controlled storage conditions (e.g., light protection, humidity control) (approximately 500 sq. feet). AT THIS TIME, ONLY CAPABILITY STATEMENTS FROM SMALL BUSINESSES ARE BEING REQUESTED. THIS NOTICE IS NOT A REQUEST FOR PROPOSALS. Capability statements must specify the offeror’s business size and type, and demonstrate similar work that has been performed in the past five years and the dollar value of that work. The required service is defined as NAICS code 541712. For purposes of this notice, a small business is defined as one that has 500 or less employees. Small businesses that believe that they have the ability to satisfy all of the above stated capabilities, and who meet the stated size standards, are encouraged to submit a capability statement. The capability statement should be limited to no more than fifteen (15) pages (including all attachments, charts, etc.) and it should address each of the competencies indicated above. All proprietary information should be marked as such. The capability statement should include a indication of current certified small business status; this indication should be clearly marked on the first page of the statement (preferably placed under the business concern’s name and address). If responses indicate the likelihood of satisfactory competition among qualified businesses, the anticipated solicitation will be restricted to small businesses only. All capability statements sent in response to this SOURCES SOUGHT notice must be submitted electronically (via email) to Dianne M. Gray, Contract Specialist, at graydi@mail.nih.gov in either MS Word or WordPerfect, or ADOBE Document Format (PDF), by January 21, 2009, 3:30PM Eastern Time. Questions regarding this requirement must be submitted in writing and directed to Dianne M. Gray at the above email address before the closing date of this notice. All responses must be received by the specified due date and time in order to be considered.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/SSPCPSB9500347/listing.html)
- Record
- SN01931992-W 20090830/090829004517-66ba30ff25eeb1344cef823b6b078c99 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |